Diagnostic and Interventional Cardiology

ROC curves of classification of healthy control (HC) and CHDs.

An Auxiliary CHD Diagnostic System Based on Multi-view and Multi-modal Transthoracic Echocardiograms

May 29, 2024 — Congenital heart disease (CHD) is one of the most common congenital anomalies worldwide, which brings a ...

May 29, 2024

Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024

News | Heart Failure

Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

May 28, 2024

The American Heart Association has issued a statement warning that false information about COVID vaccination and heart defects attributed to the Association may be spreading.

News | AHA

American Heart Association Warns of Misinformation Connecting COVID Vaccination to Heart Defects

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID ...

May 24, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Analysis adds to the body of evidence differentiating INPEFA as a dual oral inhibitor of SGLT2 and SGLT1

News | Pharmaceuticals

New Post-Hoc Analysis of Pooled Phase 3 Data Shows That Inpefa (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

May 24, 2024

An AI program developed by Cedars-Sinai investigators might help clinicians detect early, subtle changes in the hearts of patients with undiagnosed arrhythmias

News | Artificial Intelligence

AI May Help Physicians Detect Abnormal Heart Rhythms Earlier

May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their ...

May 24, 2024

A new peer-reviewed study published in the Journal of the American Heart Association, JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.

News | Cardiovascular Clinical Studies

Study in JAHA Links Hello Heart Usage to Significant Reductions in Blood Pressure, Cholesterol, and Weight

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that ...

May 23, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

The REVEALPLAQUE trial was a large, global prospective study which enrolled 258 patients across 15 sites in the U.S. and Japan

News | FFR Technologies

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced ...

May 23, 2024

News | Cardiovascular Clinical Studies

Real-life Data Highlights Need for Patient-centered Management of Unhealthy Cholesterol

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings ...

May 23, 2024

New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC)

News | Heart Failure

Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

May 22, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Voiant (USA) and Thirona (The Netherlands) are pleased to announce they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung image analysis

News | Cardiovascular Business

Voiant and Thirona Announce Commercial Partnership for Full Scope Services in Imaging-based Clinical Trials for Pulmonary Diseases

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership ...

May 22, 2024

Artificial intelligence (AI)-driven health technology company, Anumana, which developed the FDA-approved ECG-AI LEF algorithm, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System.

News | Artificial Intelligence

Cardiac Care AI Company, Anumana, Announces Receipt of ISO 13485 Certification

May 21, 2024 — Anumana, a Cambridge, MA-based artificial intelligence (AI)-driven health technology company and ...

May 21, 2024

Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa

News | EP Lab

Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

May 21, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Correlation between transcriptomic age and other epigenetic aging predictors

News | Cardiovascular Clinical Studies

Association of Inflammatory and Metabolic Biomarkers and Accelerated Aging in Cardiac Catheterization Patients

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging ...

May 21, 2024

Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the American Stroke Association’s Heart-Check mark for Acute Stroke Ready Certification

News | Stroke

Ochsner Medical Center-Baton Rouge earns Acute Stroke Ready Certification from Joint Commission

May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the ...

May 20, 2024

Cardiologist Brendan Carry, MD, and a team of Geisinger Medical Center physicians have enrolled the first patient in the U.S. into a cardiac amyloidosis trial. Image courtesy: Geisinger Medical Center/Mark Dastrup

News | Cardiovascular Clinical Studies

Geisinger Enrolls First Patient in Amyloid Cardiomyopathy Trial

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have ...

May 20, 2024